Simvastatin (40 mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects With the Metabolic Syndrome
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 100 (9), 1397-1399
- https://doi.org/10.1016/j.amjcard.2007.06.028
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT StudyMetabolism, 2007
- Adiponectin and Cardiovascular Disease: Response to Therapeutic InterventionsJournal of the American College of Cardiology, 2007
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta; International Journal of Clinical Chemistry, 2007
- The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: A pilot studyClinical Therapeutics, 2006
- The effect of fluvastatin on plasma adiponectin levels in dyslipidaemiaClinical Endocrinology, 2006
- Macrophage-secreted factors induce adipocyte inflammation and insulin resistanceBiochemical and Biophysical Research Communications, 2006
- Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 DiabetesHypertension, 2005
- Additive Beneficial Effects of Fenofibrate Combined With Atorvastatin in the Treatment of Combined HyperlipidemiaJournal of the American College of Cardiology, 2005
- Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive PatientsCirculation, 2004
- Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant statusEndocrinology and Metabolism Clinics of North America, 2004